Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday, as they were criticized for charging way more for some “critical” prescription drugs than it ...

CVS responds by saying regulator's latest report is 'inappropriate and misleading' The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday ...

The FTC turned a spotlight on “excess” price hikes on specialty generic drugs for cancer, heart disease, HIV and other conditions.

FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000% CVS responds by saying regulator’s latest report is ‘inappropriate and misleading’ Published: Jan. 14, 2025 at ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...